PCC0208017 is primarily utilized in the research and development of pharmaceuticals for treating neurological disorders, particularly those involving brain abnormalities such as Alzheimer's and Parkinson's disease. This compound has the potential to improve neuronal cell function and reduce inflammation in the brain. Additionally, preliminary studies suggest it may play a role in restoring memory and learning abilities. In the future, it could be developed into highly effective treatments for neurological disorders.